Home Healthcare Biotechnology Non-Alcoholic Steatohepatitis Biomarkers Market

Non-Alcoholic Steatohepatitis Biomarkers Market Size, Share & Trends Analysis Report By Type (Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers, Others), By End-Use (Pharma and CRO Industry, Hospitals, Diagnostic Labs, Academic Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5187DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Non-Alcoholic Steatohepatitis Biomarkers Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Serum Biomarkers
    2. Hepatic Fibrosis Biomarkers
    3. Apoptosis Biomarkers
    4. Oxidative Stress Biomarkers
    5. Others
  2. Non-Alcoholic Steatohepatitis Biomarkers Market, By End-Use 2022-2034 (USD MILLION/ Units)
    1. Pharma and CRO Industry
    2. Hospitals
    3. Diagnostic Labs
    4. Academic Research Institutes
  3. Regional Non-Alcoholic Steatohepatitis Biomarkers Market
    1. North America
      1. North America Non-Alcoholic Steatohepatitis Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
      2. North America Non-Alcoholic Steatohepatitis Biomarkers Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Pharma and CRO Industry
        2. Hospitals
        3. Diagnostic Labs
        4. Academic Research Institutes
      3. U.S.
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      4. Canada
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
    2. Europe
      1. Europe Non-Alcoholic Steatohepatitis Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
      2. Europe Non-Alcoholic Steatohepatitis Biomarkers Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Pharma and CRO Industry
        2. Hospitals
        3. Diagnostic Labs
        4. Academic Research Institutes
      3. U.K.
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      4. Germany
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      5. France
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      6. Spain
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      7. Italy
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      8. Russia
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      9. Nordic
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      10. Benelux
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      11. Rest of Europe
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
    3. APAC
      1. APAC Non-Alcoholic Steatohepatitis Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
      2. APAC Non-Alcoholic Steatohepatitis Biomarkers Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Pharma and CRO Industry
        2. Hospitals
        3. Diagnostic Labs
        4. Academic Research Institutes
      3. China
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      4. Korea
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      5. Japan
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      6. India
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      7. Australia
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      8. Singapore
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      9. Taiwan
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      10. South East Asia
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      11. Rest of Asia-Pacific
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
    4. Middle East and Africa
      1. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
      2. Middle East and Africa Non-Alcoholic Steatohepatitis Biomarkers Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Pharma and CRO Industry
        2. Hospitals
        3. Diagnostic Labs
        4. Academic Research Institutes
      3. UAE
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      4. Turkey
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      5. Saudi Arabia
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      6. South Africa
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      7. Egypt
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      8. Nigeria
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      9. Rest of MEA
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
    5. LATAM
      1. LATAM Non-Alcoholic Steatohepatitis Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
      2. LATAM Non-Alcoholic Steatohepatitis Biomarkers Market By End-Use 2022-2034 (USD MILLION/ Units)
        1. Pharma and CRO Industry
        2. Hospitals
        3. Diagnostic Labs
        4. Academic Research Institutes
      3. Brazil
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      4. Mexico
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      5. Argentina
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      6. Chile
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      7. Colombia
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
      8. Rest of LATAM
        1. Serum Biomarkers
        2. Hepatic Fibrosis Biomarkers
        3. Apoptosis Biomarkers
        4. Oxidative Stress Biomarkers
        5. Others
        6. Pharma and CRO Industry
        7. Hospitals
        8. Diagnostic Labs
        9. Academic Research Institutes
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.